Menu

Many Editors of US Medical Journals Receive Industry Funding

The authors of two new studies on the payments suggest stricter guidelines are needed.

Nov 8, 2017
Shawna Williams

ISTOCK, APPLEUZRRead through a paper in a reputable medical journal, and chances are that if its authors have a conflict of interest related to its contents—if they receive licensing payments for the technology described, for example, or research funding from industry—that information will be disclosed. But if the journal editor who decided to publish the paper has such a conflict of interest, that information is unlikely to be so easy to find.

In two studies published late last month in PeerJ (October 20) and The BMJ (October 26), researchers ran the names of editors of 35 (PeerJ) and 52 (BMJ) top US-based medical journals through the Open Payments database and found that the majority—63 percent of physician-editors in the PeerJ study, and just over half of higher-ranking editors in the BMJ study—had received industry payments in recent years.

STAT notes that in the BMJ report, the median take among the editors receiving industry funds in 2014 was just $11. However, two received more than $1 million each.

“[J]ournal editors are the ones who choose which manuscripts are sent out for peer review, who those peer reviewers are, and ultimately decide what gets published and what doesn’t. Because of their large role in shaping science, the biases of journal editors should be under closer scrutiny,” Victoria Wong, an author of the PeerJ study, tells Retraction Watch.

Wong adds, “The more funds that come from industry, the greater the likelihood that editorial decisions are not objective. It is unfortunate that we’re discussing the incomes of the very people who are the gatekeepers of the medical research that drives health care policy and expenditure, yet our current system does not think it important enough to provide them with a dedicated and unbiased source of income to do this job.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.